These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 32694863)

  • 21. Nonalcoholic Fatty Liver Disease 2020: The State of the Disease.
    Cotter TG; Rinella M
    Gastroenterology; 2020 May; 158(7):1851-1864. PubMed ID: 32061595
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NAFLD: Challenges and opportunities to address the public health problem in Latin America.
    Arab JP; Díaz LA; Dirchwolf M; Mark HE; Lazarus JV; Vaughan E; Méndez-Sánchez N; Oliveira CP; Gadano A; Arrese M
    Ann Hepatol; 2021; 24():100359. PubMed ID: 34004366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cardiovascular Risk in Children with Nonalcoholic Fatty Liver Disease (NAFLD).
    Chociej AB; Wasilewska N; Flisiak-Jackiewicz M; Lebensztejn D
    Curr Pediatr Rev; 2020; 16(4):294-297. PubMed ID: 33038914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Natural History of Nonalcoholic Fatty Liver Disease.
    Goh GB; McCullough AJ
    Dig Dis Sci; 2016 May; 61(5):1226-33. PubMed ID: 27003142
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nonalcoholic fatty liver disease: a comprehensive review of a growing epidemic.
    Hassan K; Bhalla V; El Regal ME; A-Kader HH
    World J Gastroenterol; 2014 Sep; 20(34):12082-101. PubMed ID: 25232245
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Nonalcoholic Fatty Liver Disease in Children: Unique Considerations and Challenges.
    Goldner D; Lavine JE
    Gastroenterology; 2020 May; 158(7):1967-1983.e1. PubMed ID: 32201176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention.
    Huang DQ; El-Serag HB; Loomba R
    Nat Rev Gastroenterol Hepatol; 2021 Apr; 18(4):223-238. PubMed ID: 33349658
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relation of physical activity to prevalence of nonalcoholic Fatty liver disease independent of cardiometabolic risk.
    Oni ET; Kalathiya R; Aneni EC; Martin SS; Blaha MJ; Feldman T; Agatston AS; Blumenthal RS; Conceiçao RD; Carvalho JA; Santos RD; Nasir K
    Am J Cardiol; 2015 Jan; 115(1):34-9. PubMed ID: 25456868
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nonalcoholic Fatty Liver Disease Pandemic Fuels the Upsurge in Cardiovascular Diseases.
    Cai J; Zhang XJ; Ji YX; Zhang P; She ZG; Li H
    Circ Res; 2020 Feb; 126(5):679-704. PubMed ID: 32105577
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Association of nonalcoholic fatty liver disease with cardiovascular risk factors in obese adolescents: the role of interdisciplinary therapy.
    Sanches PL; de Piano A; Campos RM; Carnier J; de Mello MT; Elias N; Fonseca FA; Masquio DC; da Silva PL; Corgosinho FC; Tock L; Oyama LM; Tufik S; Dâmaso AR
    J Clin Lipidol; 2014; 8(3):265-72. PubMed ID: 24793347
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations for Management and Treatment of Nonalcoholic Steatohepatitis.
    Ratziu V; Ghabril M; Romero-Gomez M; Svegliati-Baroni G
    Transplantation; 2019 Jan; 103(1):28-38. PubMed ID: 30300289
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Lower fructose intake may help protect against development of nonalcoholic fatty liver in adolescents with obesity.
    OʼSullivan TA; Oddy WH; Bremner AP; Sherriff JL; Ayonrinde OT; Olynyk JK; Beilin LJ; Mori TA; Adams LA
    J Pediatr Gastroenterol Nutr; 2014 May; 58(5):624-31. PubMed ID: 24345826
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bariatric Surgery Versus Standard Obesity Treatment and the Risk of Severe Liver Disease: Data From the Swedish Obese Subjects Study.
    Hagström H; Ekstedt M; Olbers T; Peltonen M; Carlsson L
    Clin Gastroenterol Hepatol; 2021 Dec; 19(12):2675-2676.e2. PubMed ID: 33161161
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Obesity and liver disease: the epidemic of the twenty-first century.
    Corey KE; Kaplan LM
    Clin Liver Dis; 2014 Feb; 18(1):1-18. PubMed ID: 24274861
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030.
    Estes C; Anstee QM; Arias-Loste MT; Bantel H; Bellentani S; Caballeria J; Colombo M; Craxi A; Crespo J; Day CP; Eguchi Y; Geier A; Kondili LA; Kroy DC; Lazarus JV; Loomba R; Manns MP; Marchesini G; Nakajima A; Negro F; Petta S; Ratziu V; Romero-Gomez M; Sanyal A; Schattenberg JM; Tacke F; Tanaka J; Trautwein C; Wei L; Zeuzem S; Razavi H
    J Hepatol; 2018 Oct; 69(4):896-904. PubMed ID: 29886156
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Letter to the editor: Treating nonalcoholic fatty liver disease with statins. Are all statins equal?
    Athyros VG; Katsiki N; Mikhailidis DP
    Am J Physiol Gastrointest Liver Physiol; 2017 Jun; 312(6):G681-G682. PubMed ID: 28596414
    [No Abstract]   [Full Text] [Related]  

  • 37. Growing burden of nonalcoholic fatty liver disease in Turkey: A single-center experience.
    Yılmaz Y; Kanı HT; Demirtaş CÖ; Kaya E; Sapmaz AF; Qutranji L; Alkayyali T; Batun KD; Batman M; Toy B; Çiftaslan A
    Turk J Gastroenterol; 2019 Oct; 30(10):892-898. PubMed ID: 31258138
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nonalcoholic fatty liver disease: epidemiology, pathogenesis and therapeutic implications.
    Andronescu CI; Purcarea MR; Babes PA
    J Med Life; 2018; 11(1):20-23. PubMed ID: 29696060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Risk factor compositions of nonalcoholic fatty liver disease change with body mass index in males and females.
    Wang L; Guo J; Lu J
    Oncotarget; 2016 Jun; 7(24):35632-35642. PubMed ID: 27248665
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alimentary regimen in non-alcoholic fatty liver disease: Mediterranean diet.
    Abenavoli L; Milic N; Peta V; Alfieri F; De Lorenzo A; Bellentani S
    World J Gastroenterol; 2014 Dec; 20(45):16831-40. PubMed ID: 25492997
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.